Semin Respir Crit Care Med 2020; 41(01): 031-041
DOI: 10.1055/s-0039-3400281
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Blastomycosis

Ilan S. Schwartz
1   Division of Infectious Diseases, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
,
Carol A. Kauffman
2   Infectious Diseases Division, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, Michigan
› Author Affiliations
Further Information

Publication History

Publication Date:
30 January 2020 (online)

Abstract

Blastomycosis is a serious fungal disease of humans and other mammals caused by environmentally acquired infection with geographically restricted, thermally dimorphic fungi belonging to the genus Blastomyces. The genetic and geographic diversity of these pathogens is greater than previously appreciated. In addition to Blastomyces dermatitidis and the cryptic species Blastomyces gilchristii, which cause blastomycosis in mid-western and various eastern areas of North America, atypical blastomycosis is occasionally caused by Blastomyces helicus in western parts of North America and Blastomyces percursus in Africa. Blastomycosis is acquired by inhalation of the conidia that are produced in the mold phase; in the lungs, temperature-dependent transformation occurs to the yeast phase. In this form, the organism is phagocytized by macrophages and can spread hematogenously to various organs causing disseminated infection. Pulmonary disease is most common and varies from mild, self-limited infection to severe, potentially fatal adult respiratory distress syndrome. Disseminated infection is manifested primarily by skin lesions, but many other organs can be involved. Diagnosis is established by growth of the organism in culture; however, a tentative diagnosis can be made quickly by histopathological identification of the classic yeast form in tissues or by finding Blastomyces antigen in urine or serum. Blastomycosis is treated initially with amphotericin B when the disease is severe, involves the central nervous system, or the host is immunosuppressed. Itraconazole is recommended for primary therapy in mild-to-moderate infection and for step-down therapy after initial amphotericin B treatment. Voriconazole and posaconazole can be used for patients in whom itraconazole is not tolerated.

 
  • References

  • 1 Gilchrist TC, Stokes WR. A case of pseudo-lupus vulgaris caused by a Blastomyces . J Exp Med 1898; 3 (01) 53-78
  • 2 Jiang YP, Dukik K, Munoz JF. , et al. Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis . Fungal Divers 2018; 90: 245-291
  • 3 Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010; 23 (02) 367-381
  • 4 Meece JK, Anderson JL, Fisher MC, Henk DA, Sloss BL, Reed KD. Population genetic structure of clinical and environmental isolates of Blastomyces dermatitidis, based on 27 polymorphic microsatellite markers. Appl Environ Microbiol 2011; 77 (15) 5123-5131
  • 5 Brown EM, McTaggart LR, Zhang SX, Low DE, Stevens DA, Richardson SE. Phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis . PLoS One 2013; 8 (03) e59237
  • 6 McTaggart LR, Brown EM, Richardson SE. Phylogeographic analysis of Blastomyces dermatitidis and Blastomyces gilchristii reveals an association with North American freshwater drainage basins. PLoS One 2016; 11 (07) e0159396
  • 7 Dwight PJ, Naus M, Sarsfield P, Limerick B. An outbreak of human blastomycosis: the epidemiology of blastomycosis in the Kenora catchment region of Ontario, Canada. Can Commun Dis Rep 2000; 26 (10) 82-91
  • 8 Centers for Disease Control and Prevention (CDC). Blastomycosis—Wisconsin, 1986-1995. MMWR Morb Mortal Wkly Rep 1996; 45 (28) 601-603
  • 9 Thompson K, Sterkel AK, Brooks EG. Blastomycosis in Wisconsin: beyond the outbreaks. Acad Forensic Pathol 2017; 7 (01) 119-129
  • 10 Dukik K, Muñoz JF, Jiang Y. , et al. Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales). Mycoses 2017; 60 (05) 296-309
  • 11 Sigler L. Emmonsia helica Sigler sp. nov. Index Fungorum 2015; 237: 308
  • 12 Schwartz IS, Wiederhold NP, Hanson KE, Patterson TF, Sigler L. Blastomyces helicus, a new dimorphic fungus causing fatal pulmonary and systemic disease in humans and animals in western Canada and the United States. Clin Infect Dis 2019; 68 (02) 188-195
  • 13 Peterson SW, Sigler L. Molecular genetic variation in Emmonsia crescens and Emmonsia parva, etiologic agents of adiaspiromycosis, and their phylogenetic relationship to Blastomyces dermatitidis (Ajellomyces dermatitidis) and other systemic fungal pathogens. J Clin Microbiol 1998; 36 (10) 2918-2925
  • 14 Sigler L. Adiaspiromycosis and other infections caused by Emmonsia species . In: Hay RJ, Merz WG. , eds. Topley and Wilson's Microbiology and Microbial Infections. 10th ed. London: Arnold Hodder; 2005: 809-824
  • 15 Kenyon C, Bonorchis K, Corcoran C. , et al. A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med 2013; 369 (15) 1416-1424
  • 16 Drouhet E, Gueho E, Gori S. , et al. Mycological, ultrastructural and experimental aspects of a new dimorphic fungus, Emmonsia pasteuriana sp. nov. isolated from a cutaneous disseminated mycosis in AIDS. J Mycol Med 1998; 8: 64-77
  • 17 Schwartz IS, Kenyon C, Feng P. , et al. 50 years of Emmonsia disease in humans: the dramatic emergence of a cluster of novel fungal pathogens. PLoS Pathog 2015; 11 (11) e1005198
  • 18 Borman AM, Jiang Y, Dukik K, Sigler L, Schwartz IS, de Hoog GS. Adiaspiromycosis and diseases caused by related fungi in Ajellomycetaceae . In: Seyedmousavi S, de Hoog GS, Guillot J, Verweij PE. , eds. Emerging and Epizootic Fungal Infections in Animals. Cham: Springer International Publishing; 2018: 147-158
  • 19 Seitz AE, Younes N, Steiner CA, Prevots DR. Incidence and trends of blastomycosis-associated hospitalizations in the United States. PLoS One 2014; 9 (08) e105466
  • 20 Crampton TL, Light RB, Berg GM. , et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis 2002; 34 (10) 1310-1316
  • 21 Baumgardner DJ, Buggy BP, Mattson BJ, Burdick JS, Ludwig D. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis 1992; 15 (04) 629-635
  • 22 Lohrenz S, Minion J, Pandey M, Karunakaran K. Blastomycosis in Southern Saskatchewan 2000-2015: unique presentations and disease characteristics. Med Mycol 2018; 56 (07) 787-795
  • 23 McDonald R, Dufort E, Jackson BR. , et al. Notes from the field: blastomycosis cases occurring outside of regions with known endemicity—New York, 2007–2017. MMWR Morb Mortal Wkly Rep 2018; 67 (38) 1077-1078
  • 24 Restrepo A, Baumgardner DJ, Bagagli E. , et al. Clues to the presence of pathogenic fungi in certain environments. Med Mycol 2000; 38 (Suppl. 01) 67-77
  • 25 Baumgardner DJ, Knavel EM, Steber D, Swain GR. Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: association with urban watersheds. Mycopathologia 2006; 161 (05) 275-282
  • 26 Burgess JW, Schwan WR, Volk TJ. PCR-based detection of DNA from the human pathogen Blastomyces dermatitidis from natural soil samples. Med Mycol 2006; 44 (08) 741-748
  • 27 Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72 (05) 311-325
  • 28 Schwartz IS. Blastomycosis in mammals. In: Seyedmousavi S, de Hoog GS, Guillot J, Verweij PE. , eds. Emerging and Epizootic Fungal Infections in Animals. Springer; 2018: 159-176
  • 29 Baumgardner DJ, Burdick JS. An outbreak of human and canine blastomycosis. Rev Infect Dis 1991; 13 (05) 898-905
  • 30 Baumgardner DJ, Egan G, Giles S, Laundre B. An outbreak of blastomycosis on a United States Indian reservation. Wilderness Environ Med 2002; 13 (04) 250-252
  • 31 Kitchen MS, Reiber CD, Eastin GB. An urban epidemic of North American blastomycosis. Am Rev Respir Dis 1977; 115 (06) 1063-1066
  • 32 Pfister JR, Archer JR, Hersil S. , et al. Non-rural point source blastomycosis outbreak near a yard waste collection site. Clin Med Res 2011; 9 (02) 57-65
  • 33 Roy M, Benedict K, Deak E. , et al. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis 2013; 57 (05) 655-662
  • 34 Carlos WG, Rose AS, Wheat LJ. , et al. Blastomycosis in Indiana: digging up more cases. Chest 2010; 138 (06) 1377-1382
  • 35 Armstrong CW, Jenkins SR, Kaufman L, Kerkering TM, Rouse BS, Miller Jr GB. Common-source outbreak of blastomycosis in hunters and their dogs. J Infect Dis 1987; 155 (03) 568-570
  • 36 Klein BS, Vergeront JM, Weeks RJ. , et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986; 314 (09) 529-534
  • 37 Merkhofer Jr RM, O'Neill MB, Xiong D. , et al. Investigation of genetic susceptibility to blastomycosis reveals Interleukin-6 as a potential susceptibility locus. MBio 2019; 10 (03) 10
  • 38 De Groote MA, Bjerke R, Smith H, Rhodes III LV. Expanding epidemiology of blastomycosis: clinical features and investigation of 2 cases in Colorado. Clin Infect Dis 2000; 30 (03) 582-584
  • 39 Hannah EL, Bailey AM, Hajjeh R, Gershman K, Lindsley M, Hoffman RE. Public health response to 2 clinical cases of blastomycosis in Colorado residents. Clin Infect Dis 2001; 32 (11) E151-E153
  • 40 Centers for Disease Control and Prevention (CDC). Blastomycosis acquired occupationally during prairie dog relocation—Colorado, 1998. MMWR Morb Mortal Wkly Rep 1999; 48 (05) 98-100
  • 41 Kemna ME, Weinberger M, Sigler L, Zeltser R, Polachek I, Salkin IF. A primary oral blastomycosis-like infection in Israel. Paper presented at: American Society of Microbiology 93rd General Meeting; 1994 ; Las Vegas, Nevada: ASM
  • 42 Schwartz IS, Wiederhold NP, Kenyon CR. , et al. Human and veterinary blastomycosis caused by Blastomyces helicus and B. percursus identified among global fungal collections. Med Mycol 2018; 56: S69
  • 43 McBride JA, Gauthier GM, Klein BS. Turning on virulence: mechanisms that underpin the morphologic transition and pathogenicity of Blastomyces . Virulence 2018; 10 (01) 1-24
  • 44 Brandhorst TT, Wüthrich M, Warner T, Klein B. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis . J Exp Med 1999; 189 (08) 1207-1216
  • 45 Sterkel AK, Mettelman R, Wüthrich M, Klein BS. The unappreciated intracellular lifestyle of Blastomyces dermatitidis . J Immunol 2015; 194 (04) 1796-1805
  • 46 Gray NA, Baddour LM. Cutaneous inoculation blastomycosis. Clin Infect Dis 2002; 34 (10) E44-E49
  • 47 Ducrest V, Chuard C, Regamey C. [Blastomycosis 30 years after living in Africa]. Rev Med Suisse Romande 2000; 120 (01) 51-53
  • 48 Anderson JL, Meece JK, Hall MC, Frost HM. Evidence of delayed dissemination or re-infection with Blastomyces in two immunocompetent hosts. Med Mycol Case Rep 2016; 13: 9-11
  • 49 Kralt D, Light B, Cheang M. , et al. Clinical characteristics and outcomes in patients with pulmonary blastomycosis. Mycopathologia 2009; 167 (03) 115-124
  • 50 Lemos LB, Baliga M, Guo M. Blastomycosis: the great pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol 2002; 6 (03) 194-203
  • 51 Recht LD, Philips JR, Eckman MR, Sarosi GA. Self-limited blastomycosis: a report of thirteen cases. Am Rev Respir Dis 1979; 120 (05) 1109-1112
  • 52 Patel RG, Patel B, Petrini MF, Carter III RR, Griffith J. Clinical presentation, radiographic findings, and diagnostic methods of pulmonary blastomycosis: a review of 100 consecutive cases. South Med J 1999; 92 (03) 289-295
  • 53 Alpern JD, Bahr NC, Vazquez-Benitez G, Boulware DR, Sellman JS, Sarosi GA. Diagnostic delay and antibiotic overuse in acute pulmonary blastomycosis. Open Forum Infect Dis 2016; 3 (02) ofw078
  • 54 Ronald S, Strzelczyk J, Moore S. , et al. Computed tomographic scan evaluation of pulmonary blastomycosis. Can J Infect Dis Med Microbiol 2009; 20 (04) 112-116
  • 55 Lemos LB, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 2001; 5 (01) 1-9
  • 56 Azar MM, Assi R, Relich RF. , et al. Blastomycosis in Indiana: clinical and epidemiologic patterns of disease gleaned from a multicenter retrospective study. Chest 2015; 148 (05) 1276-1284
  • 57 Vasquez JE, Mehta JB, Agrawal R, Sarubbi FA. Blastomycosis in northeast Tennessee. Chest 1998; 114 (02) 436-443
  • 58 Lu J, Thuraisingam T, Chergui M, Wang B, Yansouni CP. Fatal blastomycosis after exogenous immunosuppression in a healthy gardener. JAAD Case Rep 2018; 4 (10) 1007-1009
  • 59 Schwartz IS, Embil JM, Sharma A, Goulet S, Light RB. Management and outcomes of acute respiratory distress syndrome caused by blastomycosis: a retrospective case series. Medicine (Baltimore) 2016; 95 (18) e3538
  • 60 Watson JB, McDonald M, Schikler K. Central extracorporeal membrane oxygenation support for blastomycosis-induced septic shock. J Pediatr Intensive Care 2016; 5 (01) 32-36
  • 61 Austin A, Jones DM, Chopra A. A pregnant woman with anterior chest mass and respiratory failure: blastomycosis in a historically nonendemic area. Am J Med 2019; Jun 2. pii: S0002-9343(19)30449-8 . doi: 10.1016/j.amjmed.2019.04.048
  • 62 Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 1993; 329 (17) 1231-1236
  • 63 Kaplan W, Clifford MK. Blastomycosis. I. A review of 198 collected cases in veterans administration hospitals. Am Rev Respir Dis 1964; 89: 659-672
  • 64 Oppenheimer M, Embil JM, Black B. , et al. Blastomycosis of bones and joints. South Med J 2007; 100 (06) 570-578
  • 65 Chapman SW, Lin AC, Hendricks KA. , et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 1997; 12 (03) 219-228
  • 66 Rolnick D, Baumrucker GO. Genitourinary blastomycosis; case report and review of literature. J Urol 1958; 79 (02) 315-323
  • 67 Pappas PG, Pottage JC, Powderly WG. , et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116 (10) 847-853
  • 68 Gonyea EF. The spectrum of primary blastomycotic meningitis: a review of central nervous system blastomycosis. Ann Neurol 1978; 3 (01) 26-39
  • 69 Roos KL, Bryan JP, Maggio WW, Jane JA, Scheld WM. Intracranial blastomycoma. Medicine (Baltimore) 1987; 66 (03) 224-235
  • 70 Bush JW, Wuerz T, Embil JM, Del Bigio MR, McDonald PJ, Krawitz S. Outcomes of persons with blastomycosis involving the central nervous system. Diagn Microbiol Infect Dis 2013; 76 (02) 175-181
  • 71 Harley WB, Lomis M, Haas DW. Marked polymorphonuclear pleocytosis due to blastomycotic meningitis: case report and review. Clin Infect Dis 1994; 18 (05) 816-818
  • 72 Friedman JA, Wijdicks EF, Fulgham JR, Wright AJ. Meningoencephalitis due to Blastomyces dermatitidis: case report and literature review. Mayo Clin Proc 2000; 75 (04) 403-408
  • 73 Bariola JR, Perry P, Pappas PG. , et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010; 50 (06) 797-804
  • 74 Sarosi GA, Eckman MR, Davies SF, Laskey WK. Canine blastomycosis as a harbinger of human disease. Ann Intern Med 1979; 91 (05) 733-735
  • 75 Bradsher RW, Bariola JR. Blastomycosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE. , eds. Essentials of Clinical Mycology. 2nd ed. New York, NY: Springer; 2011: 337-348
  • 76 Martynowicz MA, Prakash UB. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest 2002; 121 (03) 768-773
  • 77 Schwartz IS, Sanche S, Wiederhold NP, Patterson TF, Sigler L. Emergomyces canadensis, a dimorphic fungus causing fatal systemic human disease in North America. Emerg Infect Dis 2018; 24 (04) 758-761
  • 78 Durkin M, Witt J, Lemonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42 (10) 4873-4875
  • 79 Connolly P, Hage CA, Bariola JR. , et al. Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay. Clin Vaccine Immunol 2012; 19 (01) 53-56
  • 80 Hage CA, Knox KS, Davis TE, Wheat LJ. Antigen detection in bronchoalveolar lavage fluid for diagnosis of fungal pneumonia. Curr Opin Pulm Med 2011; 17 (03) 167-171
  • 81 Hage CA, Davis TE, Egan L. , et al. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir Med 2007; 101 (01) 43-47
  • 82 Bariola JR, Hage CA, Durkin M. , et al. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis 2011; 69 (02) 187-191
  • 83 Frost HM, Novicki TJ. Blastomyces antigen detection for diagnosis and management of blastomycosis. J Clin Microbiol 2015; 53 (11) 3660-3662
  • 84 Van Der Veer J, Lewis RJ, Emtiazjoo AM, Allen SD, Wheat LJ, Hage CA. Cross-reactivity in the Platelia™ Aspergillus enzyme immunoassay caused by blastomycosis. Med Mycol 2012; 50 (04) 396-398
  • 85 Cummings JR, Jamison GR, Boudreaux JW, Howles MJ, Walsh TJ, Hayden RT. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis 2007; 59 (01) 113-115
  • 86 Soufleris AJ, Klein BS, Courtney BT, Proctor ME, Jones JM. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents. Clin Infect Dis 1994; 19 (01) 87-92
  • 87 Klein BS, Jones JM. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J Clin Invest 1990; 85 (01) 152-161
  • 88 Richer SM, Smedema ML, Durkin MM. , et al. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol 2014; 21 (02) 143-146
  • 89 Babady NE, Buckwalter SP, Hall L, Le Febre KM, Binnicker MJ, Wengenack NL. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol 2011; 49 (09) 3204-3208
  • 90 Sidamonidze K, Peck MK, Perez M. , et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol 2012; 50 (05) 1783-1786
  • 91 Chapman SW, Dismukes WE, Proia LA. , et al; Infectious Diseases Society of America. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46 (12) 1801-1812
  • 92 Dismukes WE, Bradsher Jr RW, Cloud GC. , et al; NIAID Mycoses Study Group. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992; 93 (05) 489-497
  • 93 Jaruratanasirikul S, Kleepkaew A. Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol 1997; 52 (03) 235-237
  • 94 Lindsay J, Mudge S, Thompson III GR. Effects of food and omeprazole on a novel formulation of super bioavailability itraconazole in healthy subjects. Antimicrob Agents Chemother 2018; 62 (12) 62
  • 95 Lestner JM, Roberts SA, Moore CB, Howard SJ, Denning DW, Hope WW. Toxicodynamics of itraconazole: implications for therapeutic drug monitoring. Clin Infect Dis 2009; 49 (06) 928-930
  • 96 Pappas PG, Bradsher RW, Kauffman CA. , et al; The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis with higher doses of fluconazole. Clin Infect Dis 1997; 25 (02) 200-205
  • 97 Pappas PG, Bradsher RW, Chapman SW. , et al; The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis with fluconazole: a pilot study. Clin Infect Dis 1995; 20 (02) 267-271
  • 98 Freifeld A, Proia L, Andes D. , et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009; 53 (04) 1648-1651
  • 99 Borgia SM, Fuller JD, Sarabia A, El-Helou P. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med Mycol 2006; 44 (07) 659-664
  • 100 Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008; 46 (02) 201-211
  • 101 Proia LA, Harnisch DO. Successful use of posaconazole for treatment of blastomycosis. Antimicrob Agents Chemother 2012; 56 (07) 4029
  • 102 Day SR, Weiss DB, Hazen KC, Moore CC. Successful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature. Diagn Microbiol Infect Dis 2014; 79 (02) 242-244
  • 103 Kauffman CA. Treatment of the midwestern endemic mycoses, blastomycosis and histoplasmosis. Curr Fungal Infect Rep 2017; 11: 67-74
  • 104 Gross BN, Ihorst G, Jung M, Wäsch R, Engelhardt M. Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature. Pharmacotherapy 2013; 33 (10) 1117-1125
  • 105 Lahm T, Neese S, Thornburg AT, Ober MD, Sarosi GA, Hage CA. Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature. Chest 2008; 133 (06) 1478-1480
  • 106 Plamondon M, Lamontagne F, Allard C, Pépin J. Corticosteroids as adjunctive therapy in severe blastomycosis-induced acute respiratory distress syndrome in an immunosuppressed patient. Clin Infect Dis 2010; 51 (01) e1-e3
  • 107 Permpalung N, Kaewpoowat Q, Prasidthrathsint K, Chongnarungsin D, Hyman CL. Pulmonary blastomycosis: a new endemic area in New York state. Mycoses 2013; 56 (05) 592-595
  • 108 Al-Fares A, Fan E, Husain S. , et al. Veno-venous extracorporeal life support for blastomycosis-associated acute respiratory distress syndrome. Perfusion 2019; (e-pub ahead of print). DOI: 10.1177/0267659119844391.
  • 109 Resch M, Kurz K, Schneider-Brachert W. , et al. Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany. BMJ Case Rep 2009; pii: bcr07.2008.0392 . doi: 10.1136/bcr.07.2008.0392. Epub 2009 Jun 28
  • 110 Bednarczyk JM, Kethireddy S, White CW. , et al. Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series. Can J Anaesth 2015; 62 (07) 807-815
  • 111 Bergeron C, Couture-Cossette A, Valiquette L, Carignan A, Grondin-Beaudoin B. Unexpected full recovery after extracorporeal membrane oxygenation for acute respiratory distress syndrome secondary to disseminated blastomycosis following prostate biopsy. Am J Respir Crit Care Med 2018; 197: A5261
  • 112 Pearson Jr SD, Bhavani S, Katsis J. , et al. Blastomycosis-related acute respiratory distress syndrome successfully managed with extracorporeal membrane oxygenation. Am J Respir Crit Care Med 2018; 197: A5251
  • 113 Servais R, Ammar MA, Gurnani PK. Treatment of pulmonary blastomycosis with high-dose liposomal amphotericin B in a patient receiving extracorporeal membrane oxygenation. BMJ Case Rep 2019; 12 (06) 12
  • 114 Low D, Denson JL. Pulmonary blastomycosis induced acute respiratory distress syndrome requiring veno-venous extra corporeal membrane oxygenation. Am J Respir Crit Care Med 2018; 197: A5254
  • 115 Moore NM, Proia LA. Severe acute respiratory distress syndrome in a liver transplant patient. Med Mycol Case Rep 2018; 21: 1-3
  • 116 Branick K, Taylor MJ, Trump MW, Wall GC. Apparent interference with extracorporeal membrane oxygenation by liposomal amphotericin B in a patient with disseminated blastomycosis receiving continuous renal replacement therapy. Am J Health Syst Pharm 2019; 76 (11) 810-813
  • 117 Pearson GJ, Chin TW, Fong IW. Case report: treatment of blastomycosis with fluconazole. Am J Med Sci 1992; 303 (05) 313-315
  • 118 Brick KE, Agger WA. Successful treatment of brainstem blastomycosis with fluconazole. Clin Med Res 2012; 10 (02) 72-74
  • 119 Lentnek AL, Lentnek IA. Successful management of Blastomyces dermatitidis meningitis. Infect Med 2006; 23: 39-41
  • 120 Bakleh M, Aksamit AJ, Tleyjeh IM, Marshall WF. Successful treatment of cerebral blastomycosis with voriconazole. Clin Infect Dis 2005; 40 (09) e69-e71
  • 121 Panicker J, Walsh T, Kamani N. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 2006; 25 (04) 377-379
  • 122 Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis 2007; 9 (04) 310-317
  • 123 Kauffman CA, Freifeld AG, Andes DR. , et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis 2014; 16 (02) 213-224
  • 124 Grim SA, Proia L, Miller R. , et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis 2012; 14 (01) 17-23
  • 125 Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996; 22 (02) 336-340